Skip to main content

Find Clinical Trials

Home
Conditions
Gammopathy, Monoclonal

Clinical trial condition

Gammopathy, Monoclonal

Explore clinical trials studying Gammopathy, Monoclonal. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Gammopathy, Monoclonal trial results

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NCT05573802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece

Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece

View Trial Details

Not Yet Recruiting

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

NCT05581875

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: Not specified

View Trial Details

Completed

Rifaximin in Patients With Monoclonal Gammopathy

NCT03820817

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Gammopathy Igg, +21 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Completed

Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)

NCT06559579

Conditions: Blood Protein Disorders, Gammopathy, Monoclonal, Hematologic Diseases, +4 more
Locations: CHU de Brest Brest, France

CHIC de Quimper Quimper, France

View Trial Details